获得的VIII因子缺乏症在一个无产期的患者中,正在进行产业诱导
Nawras Zayat1,2, Shirley Huang2, Anthony Filipovic2
1Montefiore Medical Center, Jack D Weiler Hospital, Bronx, NY, USA.
Case reports in perinatal medicine
|May 5, 2025
概括
在分娩期间获得的VIII因子缺乏是罕见的,但至关重要的. 及时诊断和多方面的治疗方法对于在产科患者中管理这种出血障碍至关重要.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
背景情况:
- 获得的VIII因子缺乏症是一种罕见的自身免疫性疾病.
- 它提出了诊断和治疗的挑战,特别是在怀孕和分娩期间.
研究的目的:
- 在分娩期间呈现一种获得的VIII因子缺乏病例.
- 在产科环境中描述与这种疾病相关的诊断和治疗挑战.
主要方法:
- 一名31岁的妇女的病例报告,在分娩诱导期间被诊断出获得的VIII因子缺乏症.
- 管理策略的审查,包括血液制品,人体因子VII,rituximab和类固醇逐渐减少.
主要成果:
- 患者出现了并发症,包括外周血液瘤,长时间的手术部位出血和皮下血液瘤.
- 成功的管理涉及治疗方法的组合.
结论:
- 在患有无法解释的长期出血和aPTT升高的患者中,应考虑获得的VIII因子缺乏症.
- 早期识别和全面管理对于有利的结果至关重要.
更多相关视频
08:13Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
5.9K
09:51Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
Published on: March 21, 2018
19.5K
相关概念视频
Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638
Anticoagulant Drugs: Low-Molecular-Weight Heparins
536
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
536
